Does OLAPARIB Cause Covid-19? 117 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 117 reports of Covid-19 have been filed in association with OLAPARIB (Lynparza). This represents 0.6% of all adverse event reports for OLAPARIB.
117
Reports of Covid-19 with OLAPARIB
0.6%
of all OLAPARIB reports
7
Deaths
59
Hospitalizations
How Dangerous Is Covid-19 From OLAPARIB?
Of the 117 reports, 7 (6.0%) resulted in death, 59 (50.4%) required hospitalization, and 4 (3.4%) were considered life-threatening.
Is Covid-19 Listed in the Official Label?
Yes, Covid-19 is listed as a known adverse reaction in the official FDA drug label for OLAPARIB.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Covid-19?
NIRMATRELVIR\RITONAVIR (22,066)
OCRELIZUMAB (11,454)
ADALIMUMAB (9,138)
DUPILUMAB (6,986)
RITUXIMAB (6,301)
LENALIDOMIDE (6,223)
TOFACITINIB (4,926)
SECUKINUMAB (3,871)
INFLIXIMAB (3,698)
TACROLIMUS (3,201)
Which OLAPARIB Alternatives Have Lower Covid-19 Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL